21 results
6-K
EX-99.1
LEGN
Legend Biotech Corporation
3 Apr 23
Legend Biotech 6-K
4:01pm
, and as an Advisor at M28. He is Chair Emeritus of the Biotechnology Innovation Organization (BIO) and a member of the BIO board and its Executive
CORRESP
pwm5 zfp26yo
11 Oct 22
Correspondence with SEC
12:00am
CORRESP
0aerrg
30 Sep 22
Correspondence with SEC
12:00am
6-K
EX-99.1
yh529
27 May 21
U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma
12:00am
6-K
EX-99.1
z4kowmjr 1w
30 Apr 21
Current report (foreign)
6:42am
20-F
z5o1re4763 ks
2 Apr 21
Annual report (foreign)
8:10am
6-K
EX-99.1
p1v55
1 Feb 21
Legend Biotech Corporation 6-K
7:15am
6-K
EX-99.1
l61guigzk4 ij
14 Dec 20
Current report (foreign)
8:10am
424B4
qjulzj93v7hkg5
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
ysi9c9reu
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
2pd pj0h8
13 May 20
Registration statement (foreign)
4:41pm
F-1
EX-10.1
rulwn64ad
13 May 20
Registration statement (foreign)
4:41pm
F-1
EX-4.4
g7a2rcumabvxihdkq1t
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
cuqdwggv
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
6ou4rwf331ir6eahnom
8 May 20
Draft registration statement (amended)
12:00am